ポッドキャスト//The Biotech Startups Podcast
The Biotech Startups Podcast

The Biotech Startups Podcast

概要

The Biotech Startups Podcast by Excedr features weekly conversations with founders, scientists, and investors driving biotech innovation. Host Jon Chee dives into the challenges of building biotech startups, from pre-seed to IPO. New episodes every Monday and Thursday.
200
エピソード
English
言語
0
購読者
0
再生回数
エピソード25
🧬 From Raw Data to Better Drugs: Deep Sequencing Antibodies | Jake Glanville Re-Release (2/4)

🧬 From Raw Data to Better Drugs: Deep Sequencing Antibodies | Jake Glanville Re-Release (2/4)

Dec 18, 2025·

"Find the thing that gets you excited, that fascinates you, and then have the thing you love be something else." We’re revisiting some of our previous episodes over the holidays this year. Our next re-release is this...

🧬 The Mayan Negotiation Secret That Built A Biotech Company | Jake Glanville Re-Release (1/4)

🧬 The Mayan Negotiation Secret That Built A Biotech Company | Jake Glanville Re-Release (1/4)

Dec 15, 2025·

"You don't always know at the time how something will be useful in the future, but if you keep following what fascinates you, those threads can re-synthesize into something powerful down the line."​ We’re revisiting...

🧬 Seed Rounds Are the New Series A: How Funding Benchmarks Shifted | Krish Ramadurai (4/4)

🧬 Seed Rounds Are the New Series A: How Funding Benchmarks Shifted | Krish Ramadurai (4/4)

Dec 11, 2025·

"The biggest problem that we're seeing right now is that the efficiency gains have not translated to enterprise value. The customer is not seeing that result transcend into unit economics yet." In this episode of The...

🧬 Controlled Chaos: Why Success Isn't Planned (And Doesn't Need To Be) | Krish Ramadurai (3/4)

🧬 Controlled Chaos: Why Success Isn't Planned (And Doesn't Need To Be) | Krish Ramadurai (3/4)

Dec 8, 2025·

"I'm only doing this because I'm already doing this or because I couldn't afford to hypothesis test." In this episode of The Biotech Startups Podcast, Krish Ramadurai, Partner at AIX Ventures, reveals his unconventional...

🧬 Why 40% of Venture Funds Failed Last Year (And How to Avoid It) | Krish Ramadurai (2/4)

🧬 Why 40% of Venture Funds Failed Last Year (And How to Avoid It) | Krish Ramadurai (2/4)

Dec 4, 2025·

"I was not like, 'Well, this partner helped me on it, and then we shared the deal.' I was like, 'I think I'm good at this because I basically did the output of an entire firm by myself, like, the first two years.'" In...

🧬 Working 3 Jobs at Harvard: How Desperation Built Conviction | Krish Ramadurai (1/4)

🧬 Working 3 Jobs at Harvard: How Desperation Built Conviction | Krish Ramadurai (1/4)

Dec 1, 2025·

"You’ve just got to embrace the suck. When everything sucks, you just execute against it. It's nice because then when that situation happens again, which adult life works like that all the time, you can be more...

🧬 Profit + Purpose: The New Model for Healthcare Investing | Parag Shah Re-Release (2/2)

🧬 Profit + Purpose: The New Model for Healthcare Investing | Parag Shah Re-Release (2/2)

Nov 27, 2025·

"Entrepreneurship is great, but, for me, family always came first. [My] wife and kids always came first. I didn't miss a single game or show or anything of the kids, whether it was at 3 PM or 5 PM or 7 PM, I did that...

🧬 How Biotech Companies Get Debt Funding (Without Revenue) | Parag Shah Re-Release (1/2)

🧬 How Biotech Companies Get Debt Funding (Without Revenue) | Parag Shah Re-Release (1/2)

Nov 24, 2025·

"I was fortunate that my parents pretty much allowed for a more experimental, open approach to education being important, but do what you want to do, right? Try different things, take healthy risks." We’re revisiting...

🧬 Big Pharma's $180B Patent Cliff: Why VCs Are Betting on Biotech | Sergey Jakimov (4/4)

🧬 Big Pharma's $180B Patent Cliff: Why VCs Are Betting on Biotech | Sergey Jakimov (4/4)

Nov 20, 2025·

"The only advice I can give to my 21-year-old self is that advice doesn't work... But whenever you actually need advice on something that you do not know how to start or how to solve or how to figure out, you should...

🧬 $25M Fund, 20 Companies, Zero Failures: A Biotech Investing Secret | Sergey Jakimov (3/4)

🧬 $25M Fund, 20 Companies, Zero Failures: A Biotech Investing Secret | Sergey Jakimov (3/4)

Nov 17, 2025·

"If you die, all your crypto doesn't make sense. All your sustainability doesn't make sense. You have not solved the major existential issue or the major existential threat that you have." In this episode of The Biotech...

🧬 The Bank Heist Model: How to Build Your Startup Team | Sergey Jakimov (2/4)

🧬 The Bank Heist Model: How to Build Your Startup Team | Sergey Jakimov (2/4)

Nov 13, 2025·

"Building a deep tech company or building anything, pretty much, like being a founder in anything, it's like planning a bank robbery. It's like putting together a crew where, you know, you need a driver, you need...

🧬 Childhood Without Tech: Building a Foundation for VC Success | Sergey Jakimov (1/4)

🧬 Childhood Without Tech: Building a Foundation for VC Success | Sergey Jakimov (1/4)

Nov 10, 2025·

"Retrospectively, this was honestly the best childhood one can get, and it was absolutely without gadgets." In this episode of The Biotech Startups Podcast, we explore the formative years of Sergey Jakimov, founding...

🧬 How Autonomous Science Will Change Drug Discovery Forever | Jimmy Sastra (Part 4/4)

🧬 How Autonomous Science Will Change Drug Discovery Forever | Jimmy Sastra (Part 4/4)

Nov 6, 2025·

"Risk management is really just planning for when things go wrong." In this final episode with Jimmy Sastra, PhD, co-founder and CEO of Monomer Bio, host Jon Chee explores how Jimmy redefines biotech leadership by...

🧬 Autonomous Labs: The Future of Cell Culture | Jimmy Sastra (Part 3/4)

🧬 Autonomous Labs: The Future of Cell Culture | Jimmy Sastra (Part 3/4)

Nov 3, 2025·

"People are looking at cells, making decisions, and then acting on them—that’s a robotics loop. I felt it could be done autonomously." In this episode of The Biotech Startups Podcast, host Jon Chee sits down with Jimmy...

🧬 Lessons From Building the World's First Robotic Cloud Lab | Jimmy Sastra (Part 2/4)

🧬 Lessons From Building the World's First Robotic Cloud Lab | Jimmy Sastra (Part 2/4)

Oct 30, 2025·

"Life is amazing, but it’s also very fragile. I could not think of a more important mission than trying to understand how life works." In this episode of The Biotech Startups Podcast, host Jon Chee continues his...

🧬 The Rebellious Mindset That Builds Successful Startups | Jimmy Sastra (Part 1/4)

🧬 The Rebellious Mindset That Builds Successful Startups | Jimmy Sastra (Part 1/4)

Oct 27, 2025·

"Maybe because of that experience, we still keep in touch. I feel fortunate that my friends and I built something together back then—even if it started with murals and late nights, it taught me about creativity, risk...

🧬 100 Discovery Interviews Built a $3M Biotech Launchpad at Berkeley | Darren Cooke (Part 4/4)

🧬 100 Discovery Interviews Built a $3M Biotech Launchpad at Berkeley | Darren Cooke (Part 4/4)

Oct 23, 2025·

"If anyone comes to me and says, 'Hey, I’ve got this idea. I think we could do something with it,' I’m like, 'You gotta take the I-Corps class first... it really changes your mindset.'" In this episode of The Biotech...

🧬 How to Turn Regulatory Chaos Into Competitive Advantage | Darren Cooke  (Part 3/4)

🧬 How to Turn Regulatory Chaos Into Competitive Advantage | Darren Cooke (Part 3/4)

Oct 20, 2025·

"If you’re not challenging what you’ve always done, you’re not going to move forward or innovate." In this episode, Darren Cooke, Interim Chief Innovation & Entrepreneurship Officer and Executive Director of the Life...

🧬 Mentors, Networks & IP: Power Moves for Biotech Startup Success | Darren Cooke (Part 2/4)

🧬 Mentors, Networks & IP: Power Moves for Biotech Startup Success | Darren Cooke (Part 2/4)

Oct 16, 2025·

"If you ever find yourself in a situation where you’re busy and bored, you really should be doing something else." In this episode, Darren Cooke, Interim Chief Innovation & Entrepreneurship Officer and Executive...

🧬 Building Berkeley's $1B Innovation Ecosystem | Darren Cooke (Part 1/4)

🧬 Building Berkeley's $1B Innovation Ecosystem | Darren Cooke (Part 1/4)

Oct 13, 2025·

"If you go down a road and then you realize, Ah, shoot. This was not what I expected, or Why am I doing this? you can do something else. Right? Yeah. Don't sweat it." In this episode, Jon Chee interviews Darren Cooke...

🧬 How to Build Your Circle When You're Starting From Zero | Sandra Shpilberg (Part 4/4)

🧬 How to Build Your Circle When You're Starting From Zero | Sandra Shpilberg (Part 4/4)

Oct 9, 2025·

"If the door's not open, it's not open. I should only be walking through doors that are open. Why am I going to knock on doors that are closed?" Sandra Shpilberg, Co-founder and COO at Adnexi, revisits her founder’s...

🧬 No VC, No Problem: Building a Profitable Exit | Sandra Shpilberg (Part 3/4)

🧬 No VC, No Problem: Building a Profitable Exit | Sandra Shpilberg (Part 3/4)

Oct 6, 2025·

“There is something that happens when we create expectations that are actually realistic, that we have a chance to delight ourselves. And then that creates this motivation to keep going and be like, Oh, this is working...

🧬 The $3B Patient Recruitment Crisis: Digital Solutions | Sandra Shpilberg (Part 2/4)

🧬 The $3B Patient Recruitment Crisis: Digital Solutions | Sandra Shpilberg (Part 2/4)

Oct 2, 2025·

“If you have an entrepreneurial spirit, what was exciting at BioMarin was that we were doing new things, innovating and creating from scratch.” In this episode of The Biotech Startups Podcast, Sandra Shpilberg...

🧬 How Trauma Informs Purpose: Building Biotech Success | Sandra Shpilberg (Part 1/4)

🧬 How Trauma Informs Purpose: Building Biotech Success | Sandra Shpilberg (Part 1/4)

Sep 29, 2025·

"I walk around the world wanting to tell everyone that healing is possible. All types of healing are possible: physical healing, mental healing, spiritual healing. Healing is possible." In this episode of The Biotech...

🧬 Why Drug Discovery Takes 15 Years (And How AI Cuts It to 3) | Andrey Doronichev (Part 4/4)

🧬 Why Drug Discovery Takes 15 Years (And How AI Cuts It to 3) | Andrey Doronichev (Part 4/4)

Sep 25, 2025·

“If our real mission is to truly help companies get drugs to patients faster and cheaper, the amount of complexity we have to solve goes way beyond science.” In this episode of The Biotech Startups Podcast, Jon Chee...

おすすめ